Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-13-006299
Filing Date
2013-11-13
Accepted
2013-11-13 09:42:45
Documents
1
Period of Report
2013-11-08

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f3steinhart_actinium.html 3  
1 OWNERSHIP DOCUMENT f3steinhart_actinium.xml 3 2163
  Complete submission text file 0001213900-13-006299.txt   3588
Mailing Address 125 ELM STREET NEW CANAAN CT 06840
Business Address
Steinhart Richard I (Reporting) CIK: 0001293789 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-52446 | Film No.: 131212877

Mailing Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017
Business Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017 212-300-2131
Actinium Pharmaceuticals, Inc. (Issuer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 6770 Blank Checks